Boule Diagnostics AB Stock

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 06:50:51 2024-04-19 am EDT 5-day change 1st Jan Change
9.86 SEK -0.20% Intraday chart for Boule Diagnostics AB +4.01% -12.12%
Sales 2024 * 580M 52.88M Sales 2025 * 620M 56.57M Capitalization 384M 35M
Net income 2024 * 28M 2.55M Net income 2025 * 41M 3.74M EV / Sales 2024 * 0.8 x
Net Debt 2024 * 77.93M 7.11M Net Debt 2025 * 75.63M 6.9M EV / Sales 2025 * 0.74 x
P/E ratio 2024 *
13.3 x
P/E ratio 2025 *
9.17 x
Employees 200
Yield 2024 *
2.07%
Yield 2025 *
3.44%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.23%
1 week+3.35%
Current month-0.50%
1 month-0.70%
3 months-16.27%
6 months+9.17%
Current year-11.94%
More quotes
1 week
9.18
Extreme 9.18
9.90
1 month
9.14
Extreme 9.14
10.40
Current year
9.05
Extreme 9.05
12.62
1 year
8.66
Extreme 8.66
12.78
3 years
8.66
Extreme 8.66
69.40
5 years
8.66
Extreme 8.66
79.60
10 years
8.66
Extreme 8.66
108.88
More quotes
Managers TitleAgeSince
Director of Finance/CFO - Dec. 31
Sales & Marketing - 21-09-30
Human Resources Officer - 22-09-30
Members of the board TitleAgeSince
Director/Board Member 63 15-12-31
Chairman 72 20-12-31
Director/Board Member 57 13-12-31
More insiders
Date Price Change Volume
24-04-19 9.86 -0.20% 302
24-04-18 9.88 +3.35% 11,066
24-04-17 9.56 -0.21% 1,013
24-04-16 9.58 +1.48% 20,871
24-04-15 9.44 -0.42% 4,404

Delayed Quote Nasdaq Stockholm, April 18, 2024 at 11:24 am EDT

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.88 SEK
Average target price
10.4 SEK
Spread / Average Target
+5.26%
Consensus